Real-time SEC alerts Start Free →
Profitelligence
Intuitive Surgical, Inc.
ISRG MEDIUM Impact

Intuitive Surgical, Inc.

Intuitive Surgical Announces Strong 2025 Financial Performance

| 8-K |Healthcare

Summary

Intuitive Surgical, Inc. reported robust preliminary financial results for the fourth quarter and full year 2025. The company experienced an 18% growth in worldwide procedures, with da Vinci procedures up 17% and Ion procedures up 44% for the quarter. Full year procedures saw a 19% increase, with da Vinci procedures up 18% and Ion procedures up 51%. The company placed 532 da Vinci surgical systems in Q4 2025, including 303 da Vinci 5 systems, compared to 493 systems in Q4 2024. Total 2025 da Vinci placements were 1,721 systems, including 870 da Vinci 5 systems. Fourth quarter 2025 revenue was approximately $2.87 billion, up 19% year-over-year, and full year 2025 revenue was approximately $10.06 billion, up 21% year-over-year. The company expects worldwide da Vinci procedures to increase approximately 13% to 15% in 2026. The unaudited results are subject to adjustment.

Profitelligence Profitelligence Alerts

Get alerts for ISRG

Be first to know when Intuitive Surgical, Inc. files with the SEC.

Set Up Alerts →

Filing Categories

Earnings Beat General Statement

Advertisement

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.

Exchange: NASDAQ Industry: Medical Instruments & Supplies Company Website →

Official SEC Documents

ISRG
ISRG Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings

Advertisement